Order Article Reprints

Tengesdal IW, Li S, Powers NE, May M, Neff CP, Joosten LAB, Marchetti C, Dinarello CA. Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers. Pharmaceuticals. 2022; 15(5):574. https://doi.org/10.3390/ph15050574

Tengesdal, Isak W., Suzhao Li, Nicholas E. Powers, Makenna May, Charles P. Neff, Leo A. B. Joosten, Carlo Marchetti, and Charles A. Dinarello. 2022. "Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers" Pharmaceuticals 15, no. 5: 574. https://doi.org/10.3390/ph15050574

Tengesdal, I. W., Li, S., Powers, N. E., May, M., Neff, C. P., Joosten, L. A. B., Marchetti, C., & Dinarello, C. A. (2022). Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers. Pharmaceuticals, 15(5), 574. https://doi.org/10.3390/ph15050574